212 related articles for article (PubMed ID: 22101450)
1. Pimobendan and its use in treating canine congestive heart failure.
Bowles D; Fry D
Compend Contin Educ Vet; 2011 Nov; 33(11):E1. PubMed ID: 22101450
[TBL] [Abstract][Full Text] [Related]
2. Pimobendan in heart failure therapy--a silver bullet?
Gordon SG; Miller MW; Saunders AB
J Am Anim Hosp Assoc; 2006; 42(2):90-3. PubMed ID: 16527909
[TBL] [Abstract][Full Text] [Related]
3. Effect of pimobendan on the incidence of arrhythmias in small breed dogs with myxomatous mitral valve degeneration.
Lake-Bakaar GA; Singh MK; Kass PH; Griffiths LG
J Vet Cardiol; 2015 Jun; 17(2):120-8. PubMed ID: 26007710
[TBL] [Abstract][Full Text] [Related]
4. Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study.
Häggström J; Boswood A; O'Grady M; Jöns O; Smith S; Swift S; Borgarelli M; Gavaghan B; Kresken JG; Patteson M; Ablad B; Bussadori CM; Glaus T; Kovacević A; Rapp M; Santilli RA; Tidholm A; Eriksson A; Belanger MC; Deinert M; Little CJ; Kvart C; French A; Rønn-Landbo M; Wess G; Eggertsdottir AV; O'Sullivan ML; Schneider M; Lombard CW; Dukes-McEwan J; Willis R; Louvet A; DiFruscia R
J Vet Intern Med; 2008; 22(5):1124-35. PubMed ID: 18638016
[TBL] [Abstract][Full Text] [Related]
5. Use of pimobendan in the management of heart failure.
Fuentes VL
Vet Clin North Am Small Anim Pract; 2004 Sep; 34(5):1145-55. PubMed ID: 15325474
[TBL] [Abstract][Full Text] [Related]
6. Effect of pimobendan on case fatality rate in Doberman Pinschers with congestive heart failure caused by dilated cardiomyopathy.
O'Grady MR; Minors SL; O'Sullivan ML; Horne R
J Vet Intern Med; 2008; 22(4):897-904. PubMed ID: 18537880
[TBL] [Abstract][Full Text] [Related]
7. Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study-A Randomized Clinical Trial.
Boswood A; Häggström J; Gordon SG; Wess G; Stepien RL; Oyama MA; Keene BW; Bonagura J; MacDonald KA; Patteson M; Smith S; Fox PR; Sanderson K; Woolley R; Szatmári V; Menaut P; Church WM; O'Sullivan ML; Jaudon JP; Kresken JG; Rush J; Barrett KA; Rosenthal SL; Saunders AB; Ljungvall I; Deinert M; Bomassi E; Estrada AH; Fernandez Del Palacio MJ; Moise NS; Abbott JA; Fujii Y; Spier A; Luethy MW; Santilli RA; Uechi M; Tidholm A; Watson P
J Vet Intern Med; 2016 Nov; 30(6):1765-1779. PubMed ID: 27678080
[TBL] [Abstract][Full Text] [Related]
8. Current use of pimobendan in canine patients with heart disease.
Boswood A
Vet Clin North Am Small Anim Pract; 2010 Jul; 40(4):571-80. PubMed ID: 20610012
[TBL] [Abstract][Full Text] [Related]
9. A review of the pharmacology and clinical uses of pimobendan.
Boyle KL; Leech E
J Vet Emerg Crit Care (San Antonio); 2012 Aug; 22(4):398-408. PubMed ID: 22928748
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal analysis of quality of life, clinical, radiographic, echocardiographic, and laboratory variables in dogs with myxomatous mitral valve disease receiving pimobendan or benazepril: the QUEST study.
Häggström J; Boswood A; O'Grady M; Jöns O; Smith S; Swift S; Borgarelli M; Gavaghan B; Kresken JG; Patteson M; Åblad B; Bussadori CM; Glaus T; Kovačević A; Rapp M; Santilli RA; Tidholm A; Eriksson A; Belanger MC; Deinert M; Little CJ; Kvart C; French A; Rønn-Landbo M; Wess G; Eggertsdottir A; Lynne O'Sullivan M; Schneider M; Lombard CW; Dukes-McEwan J; Willis R; Louvet A; DiFruscia R
J Vet Intern Med; 2013; 27(6):1441-51. PubMed ID: 24010489
[TBL] [Abstract][Full Text] [Related]
11. Short-term hemodynamic and neuroendocrine effects of pimobendan and benazapril in dogs with myxomatous mitral valve disease and congestive heart failure.
Häggström J; Lord PF; Höglund K; Ljungvall I; Jöns O; Kvart C; Hansson K
J Vet Intern Med; 2013; 27(6):1452-62. PubMed ID: 24128373
[TBL] [Abstract][Full Text] [Related]
12. Use of pimobendan in 170 cats (2006-2010).
Macgregor JM; Rush JE; Laste NJ; Malakoff RL; Cunningham SM; Aronow N; Hall DJ; Williams J; Price LL
J Vet Cardiol; 2011 Dec; 13(4):251-60. PubMed ID: 22030289
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Preclinical Myxomatous Mitral Valve Disease Receiving Pimobendan or Placebo: The EPIC Study.
Boswood A; Gordon SG; Häggström J; Wess G; Stepien RL; Oyama MA; Keene BW; Bonagura J; MacDonald KA; Patteson M; Smith S; Fox PR; Sanderson K; Woolley R; Szatmári V; Menaut P; Church WM; O'Sullivan ML; Jaudon JP; Kresken JG; Rush J; Barrett KA; Rosenthal SL; Saunders AB; Ljungvall I; Deinert M; Bomassi E; Estrada AH; Fernandez Del Palacio MJ; Moise NS; Abbott JA; Fujii Y; Spier A; Luethy MW; Santilli RA; Uechi M; Tidholm A; Schummer C; Watson P
J Vet Intern Med; 2018 Jan; 32(1):72-85. PubMed ID: 29214723
[TBL] [Abstract][Full Text] [Related]
14. Treatment of congestive heart failure.
Butson R
J Small Anim Pract; 2003 Nov; 44(11):516. PubMed ID: 14635966
[No Abstract] [Full Text] [Related]
15. Efficacy and safet of pimobendan in canine heart failure caused by myxomatous mitral valve disease.
Smith PJ; French AT; Van Israël N; Smith SG; Swift ST; Lee AJ; Corcoran BM; Dukes-McEwan J
J Small Anim Pract; 2005 Mar; 46(3):121-30. PubMed ID: 15789807
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of pimobendan in the prevention of congestive heart failure or sudden death in Doberman Pinschers with preclinical dilated cardiomyopathy (the PROTECT Study).
Summerfield NJ; Boswood A; O'Grady MR; Gordon SG; Dukes-McEwan J; Oyama MA; Smith S; Patteson M; French AT; Culshaw GJ; Braz-Ruivo L; Estrada A; O'Sullivan ML; Loureiro J; Willis R; Watson P
J Vet Intern Med; 2012; 26(6):1337-49. PubMed ID: 23078651
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of pimobendan on survival and reoccurrence of pulmonary edema in canine congestive heart failure.
Mizuno M; Yamano S; Chimura S; Hirakawa A; Takusagawa Y; Sawada T; Maetani S; Takahashi A; Mizuno T; Harada K; Shinoda A; Uchida S; Takeuchi J; Mizukoshi T; Endo M; Uechi M
J Vet Med Sci; 2017 Jan; 79(1):29-34. PubMed ID: 27644192
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of pimobendan versus benazepril for the treatment of acquired atrioventricular valvular disease in dogs.
Lombard CW; Jöns O; Bussadori CM
J Am Anim Hosp Assoc; 2006; 42(4):249-61. PubMed ID: 16822763
[TBL] [Abstract][Full Text] [Related]
19. Case-control study of the effects of pimobendan on survival time in cats with hypertrophic cardiomyopathy and congestive heart failure.
Reina-Doreste Y; Stern JA; Keene BW; Tou SP; Atkins CE; DeFrancesco TC; Ames MK; Hodge TE; Meurs KM
J Am Vet Med Assoc; 2014 Sep; 245(5):534-9. PubMed ID: 25148095
[TBL] [Abstract][Full Text] [Related]
20. Investigation of pimobendan versus benazepril in canine myxomatous valvular disease.
Boswood A; McEwan JD; French A; Little C; Swift S; Smith S; Patteson M
Vet Rec; 2003 Oct; 153(14):439-40. PubMed ID: 14582738
[No Abstract] [Full Text] [Related]
[Next] [New Search]
